For companies, the Physics on Demand programme offers the opportunity to strengthen their R&D power with innovations and facilities of the Amsterdam universities. By building collaborative partnerships, specific scientific expertise, equipment and state-of-the-art research facilities will be made available.
In addition, our Research Facilities database provides access to high-end equipment, research instruments and expertise for R&D activities.
If you are interested, please reach out to one of our business developers.
For researchers seeking to collaborate with industrial partners, the IXAnext program provides the Physics2Market Grant. This grant encourages knowledge utilisation, by helping researchers validate physics-related research. This is helpful when companies need further proof that a science-based concept or technique can indeed have a practical application before they agree to collaborate.
This financial instrument is closed for applications. The total available budget of €250,000 has been spent.
The IXAnext valorisation programme is made possible with a contribution of the City of Amsterdam.
Panel B.V., a spin-off from the University of Amsterdam, has received a loan from the Innovatiefonds Noord-Holland. This loan will enable Panel to continue building its innovative tool for inclusive participation processes. The unique method was designed by sociologists Gerben Moerman and Christiaan Bröer of the UvA Faculty of Social and Behavioural Sciences. The method […]News
Photosynthetic & Veridis, two VU start-ups, are part of the Pole Position Programme #4 by Techleap. Through the programme, like-minded industry experts who will guide the founders of Photosynthetic & Veridis on their journey towards becoming global leaders and take Pole Position. Techleap is a government funded organization to connect and empower startups to grow and sustain a productive tech community.News
Phlox, a private biotechnology spin-off from Amsterdam UMC and specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies, has secured additional seed funding to advance Phlox’s lead program aimed at rare genetic laminopathies.News